Showing 91-100 of 184 results for "".
- Obagi Eyes the Future Under New Ownershiphttps://practicaldermatology.com/news/obagi-eyes-the-future-under-new-ownership/2457973/The sale of Obagi Medical Products to the Haitong International Zhonghua Finance Acquisition Fund I, L.P. and limited partners China Regenerative Medicine International (CRMI) Ltd. is now complete. The new
- Timing of Melanoma Diagnosis, Treatment Can Mean Life or Deathhttps://practicaldermatology.com/news/timing-of-melanoma-diagnosis-treatment-can-mean-life-or-death/2458004/The sooner melanoma patients are treated, the better their survival, particularly for stage I melanoma, according to a new study from the Cleveland Clinic. The research appears online today in the Journal of the
- Dermavant Sciences Appoints Vince Ippolito as President and COOhttps://practicaldermatology.com/news/dermavant-sciences-appoints-vince-ippolito-as-president-and-coo/2458034/Dermavant Sciences, a biopharmaceutical company focused on developing therapies for dermatologic conditions, appointed Vince Ippolito as President and Chief Operating Officer. "I am extremely pleased to welcome Vince Ippolito
- FDA Approved Eucrisa (Crisaborole) for ADhttps://practicaldermatology.com/news/fda-approved-eucrisa-crisaborole-for-ad/2458344/The U.S. Food and Drug Administration approved Eucrisa (crisaborole) ointment to treat mild-to-moderate eczema in patients two years of age and older. Eucrisa, applied topically twice daily, is a phosphodiesterase 4 (PDE-4) i
- IV Glutathione for Skin Whitening is Risky Business, UK Doctor Warnshttps://practicaldermatology.com/news/iv-glutathione-for-skin-whitening-is-risky-business-uk-doctor-warns/2458444/Skin bleaching with IV glutathione is on the rise, despite potential risks, warns a doctor in The BMJ. Both the US Food and Drug Administration (FDA) and the Dermatology Society in the Philippines -- where the practice i
- Almirall Completes Investment in Suneva Medicalhttps://practicaldermatology.com/news/almirall-completes-investment-in-suneva-medical/2458900/Barcelona-based Almirall, a global pharmaceutical company, has closed a $15 million in Series C equity investment in Suneva Medical, Inc., marketer of Bellafill®. This product i
- Acanya Announces College Scholarship Programhttps://practicaldermatology.com/news/20121010-acanya_announces_college_scholarship_program/2459711/Sponsored by Valeant Dermatology, the I Acanya Succeed Scholarship program was created to help students who have had acne and have actively tried to address it. The scholarship will award a total of up to $48,000 each to three US citize
- Dr. Siegel Discusses Sedation Without Drugshttps://practicaldermatology.com/news/Dr-Siegel-Discusses-Sedation-Without-Drugs/2471217/A significant portion of today’s patient population is interested in all-natural alternatives to drugs when possible, and sedation is an area where some useful options exist, according to Daniel M. Siegel, MD. “Sedation without drugs [is important] if you have new-age patients or, I guess,
- Acne Vaccine Could Be 'Revolutionary,' Dr. Stein Gold Sayshttps://practicaldermatology.com/news/Acne-Vaccine-Could-Be-Revolutionary-Dr-Stein-Gold-Says/2471165/The next major breakthrough in acne could be a “revolutionary” vaccine targeting the strain of c. Acnes bacteria that produces the Hyl-A enzyme, Linda Stein Gold, MD, said at the Winter Clinical Hawaii 2025 meeting in Waikoloa Village, Hawaii. “It is still in early clinical trials, but I t
- Literature Review Examines Need for Better Treatment of PsO in Skin of Colorhttps://practicaldermatology.com/news/Literature-Review-Examines-Need-Better-Treatment-PsO-Skin-Color/2471097/A recent literature review on psoriasis in patients with skin of color (SOC) “invokes an important call to action by the [International Psoriasis Council],” its authors wrote I the International Journal of Dermatology. “Education on diagnosing and treating psoriasis in all populations, inc